Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen Sheridan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Journal of General Medicine|October 13, 2022
Vancomycin Loading Doses and Nephrotoxicity on Medicine Teaching ServicesPhillip Wagner, Jonathan Arnold, Kathleen Sheridan
Oncotarget|November 12, 2015
Combined inhibition of heat shock proteins 90 and 70 leads to simultaneous degradation of the oncogenic signaling proteins involved in muscle invasive bladder cancerAlice Cavanaugh, Brendon Juengst, Kathleen Sheridan, et al.
Open Forum Infectious Diseases|July 7, 2017
Risk Factors Associated With Outpatient Parenteral Antibiotic Therapy Program Failure Among Intravenous Drug UsersDeanna J Buehrle, Ryan K Shields, Neel Shah, et al.
Anaerobe|April 8, 2010
Peptostreptococcus infective endocarditis and bacteremia. Analysis of cases at a tertiary medical center and review of the literatureLucio R Minces, Ryan K Shields, Kathleen Sheridan, et al.
Open Forum Infectious Diseases|December 18, 2019
The CHROME Study, a Real-world Experience of Single- and Multiple-Dose Oritavancin for Treatment of Gram-Positive InfectionsMark Redell, Miguel Sierra-Hoffman, Maha Assi, et al.
BMC Health Services Research|March 14, 2024
Real-time evaluation and adaptation to facilitate rapid recruitment in a large, prospective cohort studyAshley Honushefsky, Eric S Wagner, Kathleen Sheridan, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|May 16, 2023
Herpes zoster ophthalmicus: frequency and risk factors for developing uncommon ocular manifestationsAidan A Dmitriev, Jamie Odden, David Mora-Boellstorff, et al.
Lab on a Chip|July 20, 2022
Bacterial chemotaxis in static gradients quantified in a biopolymer membrane-integrated microfluidic platformPiao Hu, Khanh L Ly, Le P H Pham, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 10, 2024
Outcomes Following a False-Positive Multi-Cancer Early Detection Test: Results from DETECT-A, the First Large, Prospective, Interventional MCED StudyAnne M Lennon, Adam H Buchanan, Seema P Rego, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 5, 2024
Outcomes following a false positive multi-cancer early detection (MCED) test: Results from DETECT-A, the first large, prospective, interventional MCED studyAnne Marie Lennon, Adam H Buchanan, Seema P Rego, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of General Medicine|October 13, 2022
Vancomycin Loading Doses and Nephrotoxicity on Medicine Teaching ServicesPhillip Wagner, Jonathan Arnold, Kathleen Sheridan
Oncotarget|November 12, 2015
Combined inhibition of heat shock proteins 90 and 70 leads to simultaneous degradation of the oncogenic signaling proteins involved in muscle invasive bladder cancerAlice Cavanaugh, Brendon Juengst, Kathleen Sheridan, et al.
Open Forum Infectious Diseases|July 7, 2017
Risk Factors Associated With Outpatient Parenteral Antibiotic Therapy Program Failure Among Intravenous Drug UsersDeanna J Buehrle, Ryan K Shields, Neel Shah, et al.
Anaerobe|April 8, 2010
Peptostreptococcus infective endocarditis and bacteremia. Analysis of cases at a tertiary medical center and review of the literatureLucio R Minces, Ryan K Shields, Kathleen Sheridan, et al.
Open Forum Infectious Diseases|December 18, 2019
The CHROME Study, a Real-world Experience of Single- and Multiple-Dose Oritavancin for Treatment of Gram-Positive InfectionsMark Redell, Miguel Sierra-Hoffman, Maha Assi, et al.
BMC Health Services Research|March 14, 2024
Real-time evaluation and adaptation to facilitate rapid recruitment in a large, prospective cohort studyAshley Honushefsky, Eric S Wagner, Kathleen Sheridan, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|May 16, 2023
Herpes zoster ophthalmicus: frequency and risk factors for developing uncommon ocular manifestationsAidan A Dmitriev, Jamie Odden, David Mora-Boellstorff, et al.
Lab on a Chip|July 20, 2022
Bacterial chemotaxis in static gradients quantified in a biopolymer membrane-integrated microfluidic platformPiao Hu, Khanh L Ly, Le P H Pham, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 10, 2024
Outcomes Following a False-Positive Multi-Cancer Early Detection Test: Results from DETECT-A, the First Large, Prospective, Interventional MCED StudyAnne M Lennon, Adam H Buchanan, Seema P Rego, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 5, 2024
Outcomes following a false positive multi-cancer early detection (MCED) test: Results from DETECT-A, the first large, prospective, interventional MCED studyAnne Marie Lennon, Adam H Buchanan, Seema P Rego, et al.
Pageof 2